Horizon Pharma Inc. (NASDAQ: HZNP) had its price target raised by equities researchers at Mizuho from $30.00 to $33.00. The company currently has a rating of Buy on the stock. A number of other analysts have spoken on the stock recently, and the company has earned a consensus one-year price target of $30.46, higher than the opening price of $18.90, a difference of 15.90 percent. Horizon Pharma Inc. stock has a 52-week high of $32.34.
U.S. stocks finished sharply lower on Tuesday as equities amid a slump in energy shares and continued uncertainty about the Federal Reserve’s plans for monetary policy.
The Dow Jones Industrial Average DJIA, -1.41% closed 258.05 points, or 1.4%, lower at 18,066.89, and was down nearly 300 points at its lowest.
The S&P 500 index SPX, -1.48% gave up 32.02 points, or 1.5%, at 2,127.02.
Meanwhile, the Nasdaq Composite Index COMP, -1.09% fell 56.63 points, or 1.1%, at 5,155.25.
Stock prices often move to the upside on recommendations and new price targets of professional brokerage firms.
Shares of Horizon Pharma Inc. (NASDAQ: HZNP) opened at $18.90 yesterday and traded in a range between, $18.68 and $19.30, and last traded at $19.16, which represents a change of $ 0.27 over the previous closing price.
Horizon Pharma Inc. (NASDAQ: HZNP) now has a market cap of 3.08B
The stocks average daily volume is 4,206,160 shares out of a total float 139,087,000 and some 5,548,560 shares crossed the trading desk yesterday, 101 percent higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.
While increased trading for one day will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.
Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Professional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.
With that in mind Horizon Pharma Inc. (NASDAQ: HZNP) now has a 50-day MA is $20.26 and 200-day MA is $17.49, and it has traded in a 52-week range between $12.86 – 32.34 and today’s last price is -40.75 percent off the 52 week high of $32.34.
Earnings growth is an important factor to look at when investing in stocks and investors look for companies that have grown their earnings at least 25% or more for the past 3 years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of BNB Daily News. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.